TRIM32
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein has also been localized to the nucleus, where it interacts with the activation domain of the HIV-1 Tat protein. The Tat protein activates transcription of HIV-1 genes. [provided by RefSeq]
Full Name
tripartite motif-containing 32
Function
Has an E3 ubiquitin ligase activity (PubMed:19349376, PubMed:31123703).
Ubiquitinates DTNBP1 (dysbindin) and promotes its degradation (PubMed:19349376).
May ubiquitinate BBS2 (PubMed:22500027).
Ubiquitinates PIAS4/PIASY and promotes its degradation in keratinocytes treated with UVB and TNF-alpha (By similarity).
Also acts as a regulator of autophagy by mediating formation of unanchored 'Lys-63'-linked polyubiquitin chains that activate ULK1: interaction with AMBRA1 is required for ULK1 activation (PubMed:31123703).By Similarity3 Publications
(Microbial infection) May play a significant role in mediating the biological activity of the HIV-1 Tat protein in vivo (PubMed:7778269).
Binds specifically to the activation domain of HIV-1 Tat and can also interact with the HIV-2 and EIAV Tat proteins in vivo (PubMed:7778269).
Ubiquitinates DTNBP1 (dysbindin) and promotes its degradation (PubMed:19349376).
May ubiquitinate BBS2 (PubMed:22500027).
Ubiquitinates PIAS4/PIASY and promotes its degradation in keratinocytes treated with UVB and TNF-alpha (By similarity).
Also acts as a regulator of autophagy by mediating formation of unanchored 'Lys-63'-linked polyubiquitin chains that activate ULK1: interaction with AMBRA1 is required for ULK1 activation (PubMed:31123703).By Similarity3 Publications
(Microbial infection) May play a significant role in mediating the biological activity of the HIV-1 Tat protein in vivo (PubMed:7778269).
Binds specifically to the activation domain of HIV-1 Tat and can also interact with the HIV-2 and EIAV Tat proteins in vivo (PubMed:7778269).
Biological Process
Biological Process actin ubiquitination Source:Ensembl
Biological Process axon development Source:Ensembl
Biological Process fat cell differentiation Source:BHF-UCL
Biological Process free ubiquitin chain polymerization Source:UniProtKB1 Publication
Biological Process innate immune response Source:UniProtKB1 Publication
Biological Process muscle cell cellular homeostasis Source:Ensembl
Biological Process negative regulation of fibroblast proliferation Source:BHF-UCL
Biological Process negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage Source:BHF-UCL1 Publication
Biological Process negative regulation of viral transcription Source:UniProtKB1 Publication
Biological Process positive regulation of autophagy Source:UniProtKB1 Publication
Biological Process positive regulation of cell cycle Source:BHF-UCL1 Publication
Biological Process positive regulation of cell growth Source:BHF-UCL1 Publication
Biological Process positive regulation of cell migration Source:BHF-UCL1 Publication
Biological Process positive regulation of cell motility Source:BHF-UCL
Biological Process positive regulation of chemokine (C-C motif) ligand 20 production Source:Ensembl
Biological Process positive regulation of DNA-binding transcription factor activity Source:UniProtKB1 Publication
Biological Process positive regulation of I-kappaB kinase/NF-kappaB signaling Source:UniProtKB1 Publication
Biological Process positive regulation of interleukin-17-mediated signaling pathway Source:Ensembl
Biological Process positive regulation of neurogenesis Source:BHF-UCL
Biological Process positive regulation of neuron differentiation Source:BHF-UCL
Biological Process positive regulation of NF-kappaB transcription factor activity Source:UniProtKB1 Publication
Biological Process positive regulation of protein catabolic process Source:BHF-UCL
Biological Process positive regulation of proteolysis Source:BHF-UCL1 Publication
Biological Process positive regulation of striated muscle cell differentiation Source:Ensembl
Biological Process positive regulation of tumor necrosis factor-mediated signaling pathway Source:Ensembl
Biological Process protein K48-linked ubiquitination Source:GO_Central1 Publication
Biological Process protein polyubiquitination Source:BHF-UCL1 Publication
Biological Process protein ubiquitination Source:BHF-UCL1 Publication
Biological Process response to tumor necrosis factor Source:BHF-UCL
Biological Process response to UV Source:BHF-UCL
Biological Process suppression of viral release by host Source:UniProtKB1 Publication
Biological Process tissue homeostasis Source:Ensembl
Biological Process ubiquitin-dependent protein catabolic process Source:UniProtKB1 Publication
Biological Process axon development Source:Ensembl
Biological Process fat cell differentiation Source:BHF-UCL
Biological Process free ubiquitin chain polymerization Source:UniProtKB1 Publication
Biological Process innate immune response Source:UniProtKB1 Publication
Biological Process muscle cell cellular homeostasis Source:Ensembl
Biological Process negative regulation of fibroblast proliferation Source:BHF-UCL
Biological Process negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage Source:BHF-UCL1 Publication
Biological Process negative regulation of viral transcription Source:UniProtKB1 Publication
Biological Process positive regulation of autophagy Source:UniProtKB1 Publication
Biological Process positive regulation of cell cycle Source:BHF-UCL1 Publication
Biological Process positive regulation of cell growth Source:BHF-UCL1 Publication
Biological Process positive regulation of cell migration Source:BHF-UCL1 Publication
Biological Process positive regulation of cell motility Source:BHF-UCL
Biological Process positive regulation of chemokine (C-C motif) ligand 20 production Source:Ensembl
Biological Process positive regulation of DNA-binding transcription factor activity Source:UniProtKB1 Publication
Biological Process positive regulation of I-kappaB kinase/NF-kappaB signaling Source:UniProtKB1 Publication
Biological Process positive regulation of interleukin-17-mediated signaling pathway Source:Ensembl
Biological Process positive regulation of neurogenesis Source:BHF-UCL
Biological Process positive regulation of neuron differentiation Source:BHF-UCL
Biological Process positive regulation of NF-kappaB transcription factor activity Source:UniProtKB1 Publication
Biological Process positive regulation of protein catabolic process Source:BHF-UCL
Biological Process positive regulation of proteolysis Source:BHF-UCL1 Publication
Biological Process positive regulation of striated muscle cell differentiation Source:Ensembl
Biological Process positive regulation of tumor necrosis factor-mediated signaling pathway Source:Ensembl
Biological Process protein K48-linked ubiquitination Source:GO_Central1 Publication
Biological Process protein polyubiquitination Source:BHF-UCL1 Publication
Biological Process protein ubiquitination Source:BHF-UCL1 Publication
Biological Process response to tumor necrosis factor Source:BHF-UCL
Biological Process response to UV Source:BHF-UCL
Biological Process suppression of viral release by host Source:UniProtKB1 Publication
Biological Process tissue homeostasis Source:Ensembl
Biological Process ubiquitin-dependent protein catabolic process Source:UniProtKB1 Publication
Cellular Location
Cytoplasm
Localized in cytoplasmic bodies, often located around the nucleus.
Localized in cytoplasmic bodies, often located around the nucleus.
Involvement in disease
Muscular dystrophy, limb-girdle, autosomal recessive 8 (LGMDR8):
An autosomal recessive degenerative myopathy characterized by pelvic girdle, shoulder girdle and quadriceps muscle weakness. Clinical phenotype and severity are highly variable. Disease progression is slow and most patients remain ambulatory into the sixth decade of life.
Bardet-Biedl syndrome 11 (BBS11):
A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.
An autosomal recessive degenerative myopathy characterized by pelvic girdle, shoulder girdle and quadriceps muscle weakness. Clinical phenotype and severity are highly variable. Disease progression is slow and most patients remain ambulatory into the sixth decade of life.
Bardet-Biedl syndrome 11 (BBS11):
A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.
PTM
Ubiquitinated.
View more
Anti-TRIM32 antibodies
+ Filters
Loading...
Target: TRIM32
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 2E5
Application*: WB, E
Target: TRIM32
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYJT-4746
Application*: WB
Target: TRIM32
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBYJT-4745
Application*: E, IF, WB
More Infomation
Hot products 
-
Mouse Anti-AFDN Recombinant Antibody (V2-58751) (CBMAB-L0408-YJ)
-
Rat Anti-CD34 Recombinant Antibody (MEC 14.7) (CBMAB-C10196-LY)
-
Mouse Anti-DMPK Recombinant Antibody (CBYCD-324) (CBMAB-D1200-YC)
-
Rabbit Anti-Acetyl-Histone H3 (Lys36) Recombinant Antibody (V2-623395) (CBMAB-CP0994-LY)
-
Mouse Anti-CDK7 Recombinant Antibody (CBYY-C1783) (CBMAB-C3221-YY)
-
Mouse Anti-C5AR1 Recombinant Antibody (R63) (CBMAB-C9553-LY)
-
Mouse Anti-ACKR3 Recombinant Antibody (V2-261265) (CBMAB-C1023-LY)
-
Mouse Anti-CIITA Recombinant Antibody (CBLC160-LY) (CBMAB-C10987-LY)
-
Mouse Anti-CCNH Recombinant Antibody (CBFYC-1054) (CBMAB-C1111-FY)
-
Mouse Anti-dsDNA Recombinant Antibody (22) (CBMAB-AP1954LY)
-
Mouse Anti-CAPZB Recombinant Antibody (CBYY-C0944) (CBMAB-C2381-YY)
-
Rat Anti-CD300A Recombinant Antibody (172224) (CBMAB-C0423-LY)
-
Rat Anti-FABP3 Recombinant Antibody (CBXF-2299) (CBMAB-F1612-CQ)
-
Mouse Anti-BIRC3 Recombinant Antibody (16E63) (CBMAB-C3367-LY)
-
Mouse Anti-ANXA7 Recombinant Antibody (A-1) (CBMAB-A2941-YC)
-
Rat Anti-ADGRE4 Recombinant Antibody (V2-160163) (CBMAB-F0011-CQ)
-
Rat Anti-AChR Recombinant Antibody (V2-12500) (CBMAB-0990-CN)
-
Rabbit Anti-BRCA2 Recombinant Antibody (D9S6V) (CBMAB-CP0017-LY)
-
Mouse Anti-CD2AP Recombinant Antibody (BR083) (CBMAB-BR083LY)
-
Mouse Anti-A2M Recombinant Antibody (V2-178822) (CBMAB-A0036-YC)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry




